lobbying_activities: 2687250

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2687250	6c204db0-76ba-4575-8365-38b582889bab	Q3	KNIGHT CAPITOL CONSULTANTS	40036301	EQUASHIELD, LLC	2021	third_quarter	PHA	Provisions affecting vial reuse being discussed in connection with drug pricing legislation (H.R. 5376, Build Back Better Act).	Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2021-10-18T21:18:53.907000-04:00